Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708348
SERIAL NO

14874328

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Trisubstituted bicyclic heterocyclic compounds (e.g., chromenones and quinolines) and pharmaceutical compositions,that modulate kinase activity, including PI3 kinase activity, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TWELVE THERAPEUTICS INCC/O DEERFIELD MANAGEMENT COMPANY L P 345 PARK AVENUE SOUTH 12TH FLOOR NEW YORK NY 10010

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Castro, Alfredo C Woburn, US 131 2651
Evans, Catherine A Somerville, US 51 1472
Tremblay, Martin R Melrose, US 46 1499

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00